These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21782514)

  • 1. Sequential use of letrozole and gonadotrophin in women with poor ovarian reserve: a randomized controlled trial.
    Lee VC; Chan CC; Ng EH; Yeung WS; Ho PC
    Reprod Biomed Online; 2011 Sep; 23(3):380-8. PubMed ID: 21782514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report.
    Goswami SK; Das T; Chattopadhyay R; Sawhney V; Kumar J; Chaudhury K; Chakravarty BN; Kabir SN
    Hum Reprod; 2004 Sep; 19(9):2031-5. PubMed ID: 15217999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal stimulation protocol using letrozole versus microdose flare up GnRH agonist protocol in women with poor ovarian response undergoing ICSI.
    Mohsen IA; El Din RE
    Gynecol Endocrinol; 2013 Feb; 29(2):105-8. PubMed ID: 23134528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients.
    Smitz J; Andersen AN; Devroey P; Arce JC;
    Hum Reprod; 2007 Mar; 22(3):676-87. PubMed ID: 17110397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study.
    Garcia-Velasco JA; Moreno L; Pacheco A; Guillén A; Duque L; Requena A; Pellicer A
    Fertil Steril; 2005 Jul; 84(1):82-7. PubMed ID: 16009161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An effective alternative to only gonadotrophin for controlled ovarian stimulation in unexplained infertility patients undergoing intra-uterine insemination: a clinical trial.
    Chaudhury K; Chaudhury S; Khastgir G; Purakaystha S
    J Indian Med Assoc; 2013 Sep; 111(9):589-92, 594. PubMed ID: 24968520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term androgen priming by use of aromatase inhibitor and hCG before controlled ovarian stimulation for IVF. A randomized controlled trial.
    Lossl K; Andersen CY; Loft A; Freiesleben NL; Bangsbøll S; Andersen AN
    Hum Reprod; 2008 Aug; 23(8):1820-9. PubMed ID: 18487212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Mullerian Hormone (AMH) levels in serum and follicular fluid as predictors of ovarian response in stimulated (IVF and ICSI) cycles.
    Tolikas A; Tsakos E; Gerou S; Prapas Y; Loufopoulos A
    Hum Fertil (Camb); 2011 Dec; 14(4):246-53. PubMed ID: 22088130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of aromatase inhibitor co-treatment for controlled ovarian stimulation.
    Bedaiwy MA; Forman R; Mousa NA; Al Inany HG; Casper RF
    Hum Reprod; 2006 Nov; 21(11):2838-44. PubMed ID: 16877370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphene citrate as adjuvants to recombinant follicle-stimulating hormone in controlled ovarian hyperstimulation: a prospective, randomized, blinded clinical trial.
    Barroso G; Menocal G; Felix H; Rojas-Ruiz JC; Arslan M; Oehninger S
    Fertil Steril; 2006 Nov; 86(5):1428-31. PubMed ID: 16978619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended high dose letrozole regimen versus short low dose letrozole regimen as an adjuvant to gonadotropin releasing hormone antagonist protocol in poor responders undergoing IVF-ET.
    Fouda UM; Sayed AM
    Gynecol Endocrinol; 2011 Dec; 27(12):1018-22. PubMed ID: 21714697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A randomized, controlled trial comparing follicle stimulating hormone (FSH) to human menopausal gonadotropin (hMG) in fertilization in vitro].
    Daya S; Gumby J; Hughes EG; Collins JA; Sagle MA
    Contracept Fertil Sex; 1995 Dec; 23(12):766-71. PubMed ID: 8556078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GnRH antagonist and letrozole co-treatment in diminished ovarian reserve patients: a proof-of-concept study.
    Olgan S; Humaidan P
    Reprod Biol; 2017 Mar; 17(1):105-110. PubMed ID: 28173995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?
    Schoolcraft WB; Surrey ES; Minjarez DA; Stevens JM; Gardner DK
    Fertil Steril; 2008 Jan; 89(1):151-6. PubMed ID: 17482177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing their first treatment cycle of IVF or ICSI.
    Bjercke S; Tanbo T; Abyholm T; Omland A; Opøien HK; Fedorcsak P
    Acta Obstet Gynecol Scand; 2010 Aug; 89(8):1053-60. PubMed ID: 20602599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrafollicular and serum levels of leptin during in vitro fertilization cycles: comparison between the effects of recombinant follicle-stimulating hormones and human menopausal gonadotrophin.
    Almog B; Azem F; Kapustiansky R; Azolai J; Wagman I; Levin I; Hauser R; Pauzner D; Lessing JB; Amit A; Gamzu R
    Gynecol Endocrinol; 2011 Sep; 27(9):666-8. PubMed ID: 20979539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letrozole versus human menopausal gonadotrophin in women undergoing intrauterine insemination.
    Baysoy A; Serdaroglu H; Jamal H; Karatekeli E; Ozornek H; Attar E
    Reprod Biomed Online; 2006 Aug; 13(2):208-12. PubMed ID: 16895634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization.
    Balasch J; Fábregues F; Creus M; Moreno V; Puerto B; Peñarrubia J; Carmona F; Vanrell JA
    Hum Reprod; 1996 Nov; 11(11):2400-4. PubMed ID: 8981119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective analysis of ovarian stimulation with letrozole in women undergoing artificial insemination by donor.
    Sun XJ; Jiang L; Ji LC; Nie R; Chen H; Jin L; Zhu GJ; Qian K
    Reprod Biomed Online; 2017 Apr; 34(4):354-360. PubMed ID: 28187961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients.
    Hompes PG; Broekmans FJ; Hoozemans DA; Schats R;
    Fertil Steril; 2008 Jun; 89(6):1685-93. PubMed ID: 17681325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.